News & Insights
Walsworth publishes its 2020 Year In Review Life Sciences Update. Stay up-to-date with our discussion of recent drug litigation, including Lipitor and Lexapro, device litigation, including pelvis mesh and breast implants, talc, opioids, and trends in life sciences, including CBD, COVID-19 updates and trials, and pending U.S. Supreme Court jurisdictional litigation.
Click here to read the full report.
For more information, please contact Katie Stricklin.
We use cookies to improve your experience on our site. By using our site, you consent to the use of cookies. We will not sell your information or share it except as required by law. Read more in our Privacy Policy.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
CloudFlare provides web performance and security solutions, enhancing site speed and protecting against threats.
Service URL: developers.cloudflare.com (opens in a new window)
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
You can find more information in our Walsworth LLP Privacy Policy.